Singapore, June 15, 2024 – ChemT Biotechnology was recently featured in the NUS Alumni Magazine for its pioneering work in applying artificial intelligence to biologics manufacturing.

Singapore, April 15, 2025 – ChemT Biotechnology took part in the Bio Innovation Leaders Summit (BILS) held in Singapore this week. Co-founder Dr. Ling Wu delivered a keynote address on leveraging artificial intelligence to enhance efficiency in biologics manufacturing.

Singapore, December 15, 2024 – ChemT Biotechnology is delighted to welcome Prof. Charlie Cooney, Robert T. Haslam Professor Emeritus of Chemical Engineering at MIT, as an advisor to the company.

Singapore, December 20, 2024 – ChemT Biotechnology is working closely with Cytiva, a global leader in bioprocessing and cell therapy technologies, to support innovation and progress in cell therapy manufacturing. The collaboration focuses on integrating ChemT Bio’s flagship product, Chemplify™, into key stages of T cell production.